Atropine Methobromide

溴甲阿托品

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAtropine Methobromide
Drug Alias Name溴化甲基阿托品溴甲烷阿托品甲溴阿托品溴甲托品
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsDiarrheaStomach UlcerDuodenal Ulcer +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Fudan Forward Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiarrheaStomach UlcerDuodenal Ulcer +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeA03BA01S01FA01
Related LinksWikipediaDrugBankKEGG